About the Event
Join the future of medicine — right here in Austin!
Get ready for an energizing one-and-a-half-day conference designed to keep you at the forefront of clinical care. Hosted by the respected faculty of Dell Medical School’s Department of Internal Medicine, this event is your chance to dive into the latest breakthroughs and best practices in both inpatient and outpatient treatment.
Register now »
Conference schedule
Friday, Sept. 25, 2026 | 8 a.m. to 4:45 pm; reception from 4:45 p.m. to 6 p.m.
Saturday, Sept. 26 | 8–11 a.m.
Featured speakers
Day One Keynote: Paul S. Mueller, M.D.
Holli Sadler, M.D.
Mahsa Mansouri, M.D.
Tim Mercer, M.D., MPH
Matt Hubley, D.O.
Shailaja Hayden, M.D.
Clarissa Johnston, M.D.
Avni Mody, M.D.
Boone Goodgame, M.D.
Jan Ramesh, M.D.
John Embers, M.D.
John Bertelson, M.D.
Day Two Keynote: Aliza Norwood, M.D.
Brian Lee, M.D.
Alison Messer, M.D.
Sneha Vakamudi, M.D.
Disclosure statements
Brian Lee, M.D. is on the scientific advisory board for HealthMap Solutions. Sneha Vakamudi, M.D. is on the speaker’s bureau for Bristol Myers Squibb and for Abbott Cardiovascular. John Bertelson, M.D. is on the speaker’s bureau for Eli Lilly, Eisai, Biogen. He is also a researcher for Eli Lilly, Eisai, Annovis, Actinogen, Acumen and Bristol Myers Squibb. Tim Mercer, M.D., owns stock in Bristol Myers Squibb and is the principal investigator/director of a grant from Eli Lilly.
All of the relevant financial relationships listed for these individuals have been mitigated.
The other speakers for this educational activity have no relevant financial relationship(s) with ineligible companies to disclose.
The planners of educational activity have no relevant financial relationship(s) with ineligible companies to disclose.
The CME Advisory Committee, reviewers of this educational activity, have no relevant financial relationship(s) with ineligible companies to disclose.
Accreditation statement
The University of Texas at Austin Dell Medical School is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The University of Texas at Austin Dell Medical School designates this live activity for a maximum of 8.25 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
The presentation, Updates in the Management of Substance Use Disorder, has been designated by The University of Texas at Austin Dell Medical School for .75 credit(s) of education in pain management and the prescription of opioids.
The presentation, Care of the Homeless Patient, has been designated by The University of Texas at Austin Dell Medical School for .75 credit(s) of education in medical ethics and/or professional responsibility.
The presentation, Navigating the Opioid Equation: Clinical Confidence, Patient Safety, and Risk Mitigation, has been designated by The University of Texas at Austin Dell Medical School for .75 credit(s) of education in pain management and the prescription of opioids.